Zimmer Biomet Holdings (ZBH)

$103.03 -0.13 (-0.13%)
Market Cap 20.44B
Revenue (ttm) 7.68B
Net Income (ttm) 903.70M
EPS (ttm) N/A
PE Ratio 13.11
Forward PE 12.76
Profit Margin 11.77%
Debt to Equity Ratio 0.60
Volume 1,118,500
Avg Vol 1,301,672
Day's Range N/A - N/A
Shares Out 198.10M
Stochastic %K 69%
Beta 0.67
Analysts Sell
Price Target $110.74

Company Profile

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to fa...

Industry: Medical Devices
Sector: Healthcare
Phone: 574 373 3333
Address:
345 East Main Street, Warsaw, United States
horacehearst
horacehearst Oct. 24 at 10:05 PM
$ZBH ZBH US Zimmer Biomet dominates musculoskeletal healthcare globally. Revenue surges to $7.83B TTM with operating profit soaring past $1.5B. EPS beats forecasts. The stock is a hidden gem with a forward P/E of only 12.1, severely undervalued. Massive growth and reliable dividends.
0 · Reply
SuperGreenToday
SuperGreenToday Oct. 23 at 5:12 PM
$ZBH Share Price: $102.53 Contract Selected: Mar 20, 2026 $105 Calls Buy Zone: $5.95 – $7.35 Target Zone: $10.90 – $13.32 Potential Upside: 73% ROI Time to Expiration: 147 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Oct. 23 at 4:13 PM
$ZBH RSI: 55.04, MACD: 0.6140 Vol: 2.44, MA20: 99.42, MA50: 101.60 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
JarvisFlow
JarvisFlow Oct. 22 at 2:04 PM
Canaccord Genuity has updated their rating for Zimmer Biomet Holdings ( $ZBH ) to Hold with a price target of 101.
0 · Reply
ZacksResearch
ZacksResearch Oct. 21 at 1:27 PM
$ZBH Q3 earnings preview: Can it sustain the momentum? 📈 Zimmer Biomet boasts a +3.53% Earnings ESP and a Zacks Rank #3, indicating a higher chance to beat estimates. Key growth drivers include the Hips business with new innovations and PMDA approval in Japan. Full analysis here 👉 https://www.zacks.com/stock/news/2772892/zimmer-biomet-to-report-q3-earnings-heres-what-to-expect?cid=sm-stocktwits-2-2772892-body-16808&ADID=SYND_STOCKTWITS_TWEET_2_2772892_BODY_16808
0 · Reply
ZacksResearch
ZacksResearch Oct. 21 at 12:27 PM
$ZBH earnings setup looks strong heading into Q3 💪 Growth in hip, knee, and S.E.T. segments plus new product approvals could drive solid gains when results hit Nov. 5. Full preview and expectations here 👉 https://www.zacks.com/stock/news/2772892/zimmer-biomet-to-report-q3-earnings-heres-what-to-expect?cid=sm-stocktwits-2-2772892-teaser-16807&ADID=SYND_STOCKTWITS_TWEET_2_2772892_TEASER_16807
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 21 at 10:54 AM
Enter: $ZBH NOV 21 2025 $105 CALLS Buy in Price: $3.70 - $3.89 Take Profit: $5.88 Stop Bleeding: $3.26 ROI Potential: 59% Exit Within: 3 Weeks https://moneygroup.us/alerts
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 20 at 1:30 PM
Enter: $ZBH NOV 21 2025 $105 CALLS Buy in Price: $3.12 - $3.50 Take Profit: $6.55 Stop Bleeding: $2.75 ROI Potential: 110% Exit Within: 3 Weeks https://moneygroup.us/alerts
0 · Reply
Halo202
Halo202 Oct. 20 at 1:46 AM
$ZBH $107+ by Friday
0 · Reply
SuperGreenToday
SuperGreenToday Oct. 17 at 12:48 AM
$ZBH Share Price: $99.94 Contract Selected: Jan 16, 2026 $100 Calls Buy Zone: $4.00 – $4.94 Target Zone: $6.44 – $7.87 Potential Upside: 52% ROI Time to Expiration: 91 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Latest News on ZBH
Zimmer Biomet Highlights Robotics & Musculoskeletal Product Innovations at 2025 AAHKS Annual Meeting

Oct 21, 2025, 7:30 AM EDT - 4 days ago

Zimmer Biomet Highlights Robotics & Musculoskeletal Product Innovations at 2025 AAHKS Annual Meeting

Zimmer Biomet Q3 Earnings To Highlight Innovation And Growth - Why I Think It's A Buy

Oct 12, 2025, 4:24 AM EDT - 13 days ago

Zimmer Biomet Q3 Earnings To Highlight Innovation And Growth - Why I Think It's A Buy

Zimmer Biomet Launches Two New Foot and Ankle Solutions for Complex Trauma Cases

Oct 8, 2025, 7:30 AM EDT - 17 days ago

Zimmer Biomet Launches Two New Foot and Ankle Solutions for Complex Trauma Cases

Zimmer Biomet Completes Acquisition of Monogram Technologies

Oct 7, 2025, 9:00 AM EDT - 18 days ago

Zimmer Biomet Completes Acquisition of Monogram Technologies

I2Pure Celebrates Zimmer Biomet's Historic Approval of Iodine-Treated Implant System & Confirms AAHKS Attendance

Oct 6, 2025, 8:00 AM EDT - 19 days ago

I2Pure Celebrates Zimmer Biomet's Historic Approval of Iodine-Treated Implant System & Confirms AAHKS Attendance

Zimmer Biomet Announces Webcast and Conference Call of Third Quarter 2025 Financial Results

Oct 3, 2025, 7:30 AM EDT - 22 days ago

Zimmer Biomet Announces Webcast and Conference Call of Third Quarter 2025 Financial Results

Zimmer Biomet Announces Japan PMDA Approval of World's First Iodine-Treated Total Hip Replacement System

Sep 25, 2025, 4:30 PM EDT - 4 weeks ago

Zimmer Biomet Announces Japan PMDA Approval of World's First Iodine-Treated Total Hip Replacement System

Zimmer Biomet Holdings, Inc. (ZBH) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

Sep 8, 2025, 5:47 PM EDT - 6 weeks ago

Zimmer Biomet Holdings, Inc. (ZBH) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

Zimmer Biomet to Showcase Foot and Ankle Portfolio at the American Orthopedic Foot and Ankle Society Annual Conference

Sep 4, 2025, 4:05 PM EDT - 7 weeks ago

Zimmer Biomet to Showcase Foot and Ankle Portfolio at the American Orthopedic Foot and Ankle Society Annual Conference

Zimmer Biomet Announces New Chief Medical Advisors to Help Improve Standard of Musculoskeletal Care

Aug 28, 2025, 7:30 AM EDT - 2 months ago

Zimmer Biomet Announces New Chief Medical Advisors to Help Improve Standard of Musculoskeletal Care

Zimmer Biomet Announces Quarterly Dividend for Third Quarter of 2025

Aug 27, 2025, 7:00 AM EDT - 2 months ago

Zimmer Biomet Announces Quarterly Dividend for Third Quarter of 2025

Zimmer Biomet to Present at the Annual Morgan Stanley Healthcare Conference

Aug 25, 2025, 7:30 AM EDT - 2 months ago

Zimmer Biomet to Present at the Annual Morgan Stanley Healthcare Conference

4 Stocks to Buy From a Top-Performing Fund Manager

Aug 12, 2025, 11:20 AM EDT - 2 months ago

4 Stocks to Buy From a Top-Performing Fund Manager

AMZN CRM NKE

Zimmer Biomet Holdings, Inc. (ZBH) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 3:22 PM EDT - 2 months ago

Zimmer Biomet Holdings, Inc. (ZBH) Q2 2025 Earnings Call Transcript

Zimmer Biomet's $2.08 Billion Q2 Sales Ignite Orthopedic Surge, Boosts Guidance Outlook

Aug 7, 2025, 12:50 PM EDT - 2 months ago

Zimmer Biomet's $2.08 Billion Q2 Sales Ignite Orthopedic Surge, Boosts Guidance Outlook

Zimmer Biomet raises annual profit forecast on strong demand for medical devices

Aug 7, 2025, 8:09 AM EDT - 2 months ago

Zimmer Biomet raises annual profit forecast on strong demand for medical devices

Zimmer Biomet Q2 Preview: Combining Monogram Autonomous Robotics With ROSA

Jul 21, 2025, 12:50 PM EDT - 3 months ago

Zimmer Biomet Q2 Preview: Combining Monogram Autonomous Robotics With ROSA

MONOGRAM TECHNOLOGIES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Monogram Technologies Inc. - MGRM

Jul 16, 2025, 11:36 AM EDT - 3 months ago

MONOGRAM TECHNOLOGIES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Monogram Technologies Inc. - MGRM

MGRM

Final Trades: Uber, Delta, Zimmer Holdings and Boeing

Jul 11, 2025, 2:21 PM EDT - 3 months ago

Final Trades: Uber, Delta, Zimmer Holdings and Boeing

BA UBER DAL

Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2025 Financial Results

Jul 9, 2025, 7:30 AM EDT - 3 months ago

Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2025 Financial Results

New vaccine panel meeting underway

Jun 26, 2025, 11:46 AM EDT - 4 months ago

New vaccine panel meeting underway

BDX BMY MRK UNH

Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2025

May 30, 2025, 7:00 AM EDT - 5 months ago

Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2025

Zimmer Biomet Appoints Kevin Thornal as Group President, Global Businesses and the Americas

May 27, 2025, 7:30 AM EDT - 5 months ago

Zimmer Biomet Appoints Kevin Thornal as Group President, Global Businesses and the Americas

Zimmer Biomet to Present at the Goldman Sachs 46th Annual Global Healthcare Conference

May 22, 2025, 7:30 AM EDT - 5 months ago

Zimmer Biomet to Present at the Goldman Sachs 46th Annual Global Healthcare Conference

We pay attention to policy and patients, says Zimmer Biomet CEO Ivan Tornos

May 20, 2025, 6:04 PM EDT - 5 months ago

We pay attention to policy and patients, says Zimmer Biomet CEO Ivan Tornos

These Analysts Lower Their Forecasts On Zimmer Biomet After Q1 Results

May 6, 2025, 2:22 PM EDT - 6 months ago

These Analysts Lower Their Forecasts On Zimmer Biomet After Q1 Results

Zimmer Biomet: Stronger Cash Flows Needed Before The Stock Rebounds

May 6, 2025, 7:39 AM EDT - 6 months ago

Zimmer Biomet: Stronger Cash Flows Needed Before The Stock Rebounds

Hip Implant Maker Zimmer Biomet Cuts Annual Profit Forecast On Paragon 28 Deal

May 5, 2025, 3:34 PM EDT - 6 months ago

Hip Implant Maker Zimmer Biomet Cuts Annual Profit Forecast On Paragon 28 Deal

FNA

Zimmer Biomet Holdings, Inc. (ZBH) Q1 2025 Earnings Call Transcript

May 5, 2025, 12:05 PM EDT - 6 months ago

Zimmer Biomet Holdings, Inc. (ZBH) Q1 2025 Earnings Call Transcript

Zimmer Biomet lowers 2025 profit forecast on acquisition costs, tariff uncertainty

May 5, 2025, 7:40 AM EDT - 6 months ago

Zimmer Biomet lowers 2025 profit forecast on acquisition costs, tariff uncertainty

Zimmer Biomet Announces First Quarter 2025 Financial Results

May 5, 2025, 6:30 AM EDT - 6 months ago

Zimmer Biomet Announces First Quarter 2025 Financial Results

Zimmer Biomet Completes Acquisition of Paragon 28

Apr 21, 2025, 9:00 AM EDT - 6 months ago

Zimmer Biomet Completes Acquisition of Paragon 28

Zimmer Biomet Announces Webcast and Conference Call of First Quarter 2025 Financial Results

Apr 10, 2025, 7:30 AM EDT - 7 months ago

Zimmer Biomet Announces Webcast and Conference Call of First Quarter 2025 Financial Results

PARAGON 28 INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Paragon 28, Inc. - FNA

Apr 2, 2025, 12:47 PM EDT - 7 months ago

PARAGON 28 INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Paragon 28, Inc. - FNA

FNA

Zimmer Biomet Receives CE Mark Approval for RibFix Advantage® Fixation System

Apr 1, 2025, 7:30 AM EDT - 7 months ago

Zimmer Biomet Receives CE Mark Approval for RibFix Advantage® Fixation System

Paragon 28 Announces Expiration of HSR Act Waiting Period for Pending Acquisition by Zimmer Biomet Under HSR Act

Mar 11, 2025, 4:01 PM EDT - 8 months ago

Paragon 28 Announces Expiration of HSR Act Waiting Period for Pending Acquisition by Zimmer Biomet Under HSR Act

FNA

Zimmer Biomet Highlights Diverse Portfolio of Orthopedic & Musculoskeletal Innovations at AAOS 2025 Annual Meeting

Mar 10, 2025, 7:30 AM EDT - 8 months ago

Zimmer Biomet Highlights Diverse Portfolio of Orthopedic & Musculoskeletal Innovations at AAOS 2025 Annual Meeting

Zimmer Biomet Receives FDA Clearance for Persona® Revision SoluTion™ Femur

Mar 7, 2025, 7:30 AM EST - 8 months ago

Zimmer Biomet Receives FDA Clearance for Persona® Revision SoluTion™ Femur

Zimmer Biomet Names Kristen Cardillo as Senior Vice President, Chief Communications Officer

Mar 6, 2025, 7:30 AM EST - 8 months ago

Zimmer Biomet Names Kristen Cardillo as Senior Vice President, Chief Communications Officer

Zimmer Biomet to Present at the 27th Annual Barclays Healthcare Conference

Feb 28, 2025, 7:30 AM EST - 8 months ago

Zimmer Biomet to Present at the 27th Annual Barclays Healthcare Conference

Zimmer Biomet Appoints Jehanzeb Noor as Senior Vice President, Chief Strategy, Innovation and Business Development Officer

Feb 27, 2025, 7:30 AM EST - 8 months ago

Zimmer Biomet Appoints Jehanzeb Noor as Senior Vice President, Chief Strategy, Innovation and Business Development Officer

Zimmer Biomet Launches You'll Be Back Campaign with Chief Movement Officer Arnold Schwarzenegger

Feb 26, 2025, 7:30 AM EST - 8 months ago

Zimmer Biomet Launches You'll Be Back Campaign with Chief Movement Officer Arnold Schwarzenegger

Zimmer Biomet Announces Quarterly Dividend for First Quarter of 2025

Feb 26, 2025, 7:00 AM EST - 8 months ago

Zimmer Biomet Announces Quarterly Dividend for First Quarter of 2025

Zimmer Biomet Announces Upcoming Changes to Company's Board of Directors

Feb 25, 2025, 4:05 PM EST - 8 months ago

Zimmer Biomet Announces Upcoming Changes to Company's Board of Directors

Zimmer Biomet: Adding To The Growth Profile

Feb 7, 2025, 6:45 AM EST - 9 months ago

Zimmer Biomet: Adding To The Growth Profile

Why Is Zimmer Biomet Stock Trading Lower On Thursday?

Feb 6, 2025, 1:10 PM EST - 9 months ago

Why Is Zimmer Biomet Stock Trading Lower On Thursday?

Zimmer Biomet Holdings, Inc. (ZBH) Q4 2024 Earnings Call Transcript

Feb 6, 2025, 11:54 AM EST - 9 months ago

Zimmer Biomet Holdings, Inc. (ZBH) Q4 2024 Earnings Call Transcript

Zimmer Biomet forecasts 2025 profit below estimates

Feb 6, 2025, 8:41 AM EST - 9 months ago

Zimmer Biomet forecasts 2025 profit below estimates

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Paragon 28, Inc.

Jan 31, 2025, 4:25 PM EST - 9 months ago

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Paragon 28, Inc.

FNA

Zimmer Biomet to buy Paragon 28 for $1.1 billion

Jan 28, 2025, 6:11 PM EST - 9 months ago

Zimmer Biomet to buy Paragon 28 for $1.1 billion

FNA

horacehearst
horacehearst Oct. 24 at 10:05 PM
$ZBH ZBH US Zimmer Biomet dominates musculoskeletal healthcare globally. Revenue surges to $7.83B TTM with operating profit soaring past $1.5B. EPS beats forecasts. The stock is a hidden gem with a forward P/E of only 12.1, severely undervalued. Massive growth and reliable dividends.
0 · Reply
SuperGreenToday
SuperGreenToday Oct. 23 at 5:12 PM
$ZBH Share Price: $102.53 Contract Selected: Mar 20, 2026 $105 Calls Buy Zone: $5.95 – $7.35 Target Zone: $10.90 – $13.32 Potential Upside: 73% ROI Time to Expiration: 147 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Oct. 23 at 4:13 PM
$ZBH RSI: 55.04, MACD: 0.6140 Vol: 2.44, MA20: 99.42, MA50: 101.60 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
JarvisFlow
JarvisFlow Oct. 22 at 2:04 PM
Canaccord Genuity has updated their rating for Zimmer Biomet Holdings ( $ZBH ) to Hold with a price target of 101.
0 · Reply
ZacksResearch
ZacksResearch Oct. 21 at 1:27 PM
$ZBH Q3 earnings preview: Can it sustain the momentum? 📈 Zimmer Biomet boasts a +3.53% Earnings ESP and a Zacks Rank #3, indicating a higher chance to beat estimates. Key growth drivers include the Hips business with new innovations and PMDA approval in Japan. Full analysis here 👉 https://www.zacks.com/stock/news/2772892/zimmer-biomet-to-report-q3-earnings-heres-what-to-expect?cid=sm-stocktwits-2-2772892-body-16808&ADID=SYND_STOCKTWITS_TWEET_2_2772892_BODY_16808
0 · Reply
ZacksResearch
ZacksResearch Oct. 21 at 12:27 PM
$ZBH earnings setup looks strong heading into Q3 💪 Growth in hip, knee, and S.E.T. segments plus new product approvals could drive solid gains when results hit Nov. 5. Full preview and expectations here 👉 https://www.zacks.com/stock/news/2772892/zimmer-biomet-to-report-q3-earnings-heres-what-to-expect?cid=sm-stocktwits-2-2772892-teaser-16807&ADID=SYND_STOCKTWITS_TWEET_2_2772892_TEASER_16807
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 21 at 10:54 AM
Enter: $ZBH NOV 21 2025 $105 CALLS Buy in Price: $3.70 - $3.89 Take Profit: $5.88 Stop Bleeding: $3.26 ROI Potential: 59% Exit Within: 3 Weeks https://moneygroup.us/alerts
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 20 at 1:30 PM
Enter: $ZBH NOV 21 2025 $105 CALLS Buy in Price: $3.12 - $3.50 Take Profit: $6.55 Stop Bleeding: $2.75 ROI Potential: 110% Exit Within: 3 Weeks https://moneygroup.us/alerts
0 · Reply
Halo202
Halo202 Oct. 20 at 1:46 AM
$ZBH $107+ by Friday
0 · Reply
SuperGreenToday
SuperGreenToday Oct. 17 at 12:48 AM
$ZBH Share Price: $99.94 Contract Selected: Jan 16, 2026 $100 Calls Buy Zone: $4.00 – $4.94 Target Zone: $6.44 – $7.87 Potential Upside: 52% ROI Time to Expiration: 91 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 17 at 12:47 AM
Enter: $ZBH NOV 21 2025 $100 CALLS Buy in Price: $4.50 - $4.70 Take Profit: $8.78 Stop Bleeding: $3.96 ROI Potential: 95% Exit Within: 3 Weeks https://moneygroup.us/alerts
0 · Reply
Naguara
Naguara Oct. 14 at 7:47 PM
$ZBH J&J spinning off its orthopedics division. Very interesting
0 · Reply
Kurem
Kurem Oct. 14 at 3:43 PM
$ZBH maybe i will starting buy from 85$ - 80$
0 · Reply
IncognitoBull
IncognitoBull Oct. 13 at 9:36 PM
$NMTC $ZBH
1 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 12 at 5:06 PM
Enter: $ZBH NOV 21 2025 $100 CALLS Buy in Price: $3.00 - $3.01 Take Profit: $4.21 Stop Bleeding: $2.65 ROI Potential: 40% Exit Within: 307 Minutes https://moneygroup.us/alerts
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 11 at 4:14 PM
Enter: $ZBH NOV 21 2025 $100 CALLS Buy in Price: $3.00 - $3.01 Take Profit: $4.21 Stop Bleeding: $2.65 ROI Potential: 40% Exit Within: 307 Minutes https://moneygroup.us/alerts
0 · Reply
SuperGreenToday
SuperGreenToday Oct. 10 at 9:25 PM
$ZBH Share Price: $94.71 Contract Selected: Jan 16, 2026 $95 Calls Buy Zone: $4.33 – $5.35 Target Zone: $8.14 – $9.95 Potential Upside: 77% ROI Time to Expiration: 97 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
ZacksResearch
ZacksResearch Oct. 10 at 1:44 PM
$ZBH slips post-launch — is a rebound on the horizon? 📉🔄 Despite a 0.7% dip following the launch of new foot and ankle trauma solutions, Zimmer Biomet's commitment to innovation might support a stock rebound. The company boasts an earnings yield of 8.3%, comparing favorably with the industry average of 0.1%. 📊 See what makes the investment case strong for ZBH 👉 https://www.zacks.com/stock/news/2766040/the-launch-of-foot-and-ankle-trauma-solutions-may-boost-zbh-stock?cid=sm-stocktwits-2-2766040-body-15516&ADID=SYND_STOCKTWITS_TWEET_2_2766040_BODY_15516
0 · Reply
IncognitoBull
IncognitoBull Oct. 10 at 1:34 PM
$NMTC $ZBH
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 10 at 1:09 PM
Enter: $ZBH NOV 21 2025 $100 CALLS Buy in Price: $3.97 - $4.20 Take Profit: $5.16 Stop Bleeding: $3.49 ROI Potential: 30% Exit Within: 281 Minutes https://moneygroup.us/alerts
0 · Reply
ZacksResearch
ZacksResearch Oct. 10 at 11:46 AM
$ZBH launching new trauma solutions — bullish catalyst ahead? The company’s new Foot and Ankle Trauma Solutions could strengthen its market position and fuel renewed investor interest. Find out how this launch could impact ZBH’s growth outlook 👉 https://www.zacks.com/stock/news/2766040/the-launch-of-foot-and-ankle-trauma-solutions-may-boost-zbh-stock?cid=sm-stocktwits-2-2766040-teaser-15488&ADID=SYND_STOCKTWITS_TWEET_2_2766040_TEASER_15488
0 · Reply
SuperGreenToday
SuperGreenToday Oct. 10 at 1:45 AM
$ZBH Share Price: $97.39 Contract Selected: Jan 16, 2026 $95 Calls Buy Zone: $6.46 – $7.98 Target Zone: $10.38 – $12.69 Potential Upside: 52% ROI Time to Expiration: 98 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply